z-logo
open-access-imgOpen Access
Top Pharma companies not following current good manufacturing processes: Angiotensin II receptor blockers with carcinogenic impurities: A threat to global public health
Author(s) -
Aslam Pathan
Publication year - 2019
Publication title -
neuropharmac journal
Language(s) - English
Resource type - Journals
ISSN - 2456-3927
DOI - 10.37881/1.432
Subject(s) - business , angiotensin ii , carcinogen , impurity , current (fluid) , public health , receptor , pharmacology , medicine , chemistry , biochemistry , engineering , nursing , organic chemistry , electrical engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom